FindMyKOL
Clinical trialNCT01912391CompletedPhase 3Interventional

Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder

SponsorMood and Anxiety Research, IncEnrollment30Borderline Personality Disorder
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Selegiline is superior to placebo in improving psychological and physical functioning in patients with Borderline Personality Disorder.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mood and Anxiety Research, Inc

    Fresno, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboSelegiline →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2012
Primary completion
31 Mar 2015
Completion
31 Mar 2015
Last update posted
8 Oct 2015
Registered enrollment
30
Registry id
NCT01912391
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.